NCT00181142View on ClinicalTrials.gov

The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Patients Active and Listed for Lung Transplantation
Interventions
DRUG

Zenapax

Trial Locations (1)

21287

Johns Hopkins University Hospital, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER